Nomax Inc: Drug Recall

Recall #D-0387-2021 · 04/13/2021

Class III: Low Risk

Recall Details

Recall Number: D-0387-2021
Classification: Class III
Product Type: Drug
Recalling Firm: Nomax Inc
Status: Terminated
Date Initiated: 04/13/2021
Location: Saint Louis, MO, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 78 cartons

Reason for Recall

Subpotent Drug

Product Description

Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each), Manufactured by: Nomax, Inc, St. Louis, MO 63123, NDC: 51801-008-15

Distribution Pattern

Nationwide USA

Other Recalls by Nomax Inc

Class II: Risk 04/19/2024

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class II: Risk 04/19/2024

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class II: Risk 04/19/2024

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class II: Risk 04/19/2024

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

View all recalls by Nomax Inc →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.